Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks

eLife

Volumn 3, Issue August2014, 2014, Pages 1-26

  Zhao, Hui ^a   Thienpont, Bernard ^a   Yesilyurt, Betül Tuba ^a   Moisse, Matthieu ^a   Reumers, Joke ^a   Coenegrachts, Lieve ^b   Sagaert, Xavier ^b   Schrauwen, Stefanie ^b   Smeets, Dominiek ^a   Matthijs, Gert ^a   Aerts, Stein ^a   Cools, Jan ^a   Metcalf, Alex ^c   Spurdle, Amanda ^c   Amant, Frederic ^b   Lambrechts, Diether ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924349028     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.02725     Document Type: Article

References (68)

1. 1000 Genomes Project Consortium. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491:56-65. doi: 10.1038/nature11632.
2. Albers CA, Lunter G, MacArthur DG, McVean G, Ouwehand WH, Durbin R. 2011. Dindel: accurate indel calls from short-read data. Genome Research 21:961-973. doi: 10.1101/gr.112326.110.
3. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Research 58:5248-5257.
4. Bunting SF, Callén E, Kozak ML, Kim JM, Wong N, López-Contreras AJ, Ludwig T, Baer R, Faryabi RB, Malhowski A, Chen HT, Fernandez-Capetillo O, D'Andrea A, Nussenzweig A. 2012. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Molecular Cell 46:125-135. doi: 10.1016/j.molcel.2012.02.015.
5. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, Han L, Vives L, O'Roak BJ, Sudmant PH, Shendure J, Abney M, Ober C, Eichler EE. 2012. Estimating the human mutation rate using autozygosity in a founder population. Nature Genetics 44:1277-1281. doi: 10.1038/ng.2418.
6. Chen CL, Rappailles A, Duquenne L, Huvet M, Guilbaud G, Farinelli L, Audit B, d'Aubenton-Carafa Y, Arneodo A, Hyrien O, Thermes C. 2010. Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes. Genome Research 20:447-457. doi: 10.1101/gr.098947.109.
7. Chen J, Miller BF, Furano AV. 2014. Repair of naturally occurring mismatches can induce mutations in flanking DNA. eLife 3:e02001. doi: 10.7554/eLife.02001.
8. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS. 2004. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clinical Cancer Research 10:191-195. doi: 10.1158/1078-0432.CCR-1118-3.
9. Denver DR, Feinberg S, Estes S, Thomas WK, Lynch M. 2005. Mutation rates, spectra and hotspots in mismatch repair-deficient Caenorhabditis elegans. Genetics 170:107-113. doi: 10.1534/genetics.104.038521.
10. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Rüschoff J. 1997. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Research 57:4749-4756.
11. Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR, Gibbs RA, Wheeler D. 2013. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. The Journal of Pathology 229:99-110. doi: 10.1002/path.4087.
12. Dorard C, de Thonel A, Collura A, Marisa L, Svrcek M, Lagrange A, Jego G, Wanherdrick K, Joly AL, Buhard O, Gobbo J, Penard-Lacronique V, Zouali H, Tubacher E, Kirzin S, Selves J, Milano G, Etienne-Grimaldi MC, Bengrine-Lefèvre L, Louvet C, Tournigand C, Lefèvre JH, Parc Y, Tiret E, Fléjou JF, Gaub MP, Garrido C, Duval A. 2011. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. Nature Medicine 17:1283-1289. doi: 10.1038/nm.2457.
13. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, Dahl F, Fernandez A, Staker B, Pant KP, Baccash J, Borcherding AP, Brownley A, Cedeno R, Chen L, Chernikoff D, Cheung A, Chirita R, Curson B, Ebert JC, Hacker CR, Hartlage R, Hauser B, Huang S, Jiang Y, Karpinchyk V, Koenig M, Kong C, Landers T, Le C, Liu J, McBride CE, Morenzoni M, Morey RE, Mutch K, Perazich H, Perry K, Peters BA, Peterson J, Pethiyagoda CL, Pothuraju K, Richter C, Rosenbaum AM, Roy S, Shafto J, Sharanhovich U, Shannon KW, Sheppy CG, Sun M, Thakuria JV, Tran A, Vu D, Zaranek AW, Wu X, Drmanac S, Oliphant AR, Banyai WC, Martin B, Ballinger DG, Church GM, Reid C A. 2010. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327:78-81. doi: 10.1126/science.1181498.
14. Ellegren H. 2004. Microsatellites: simple sequences with complex evolution. Nature Reviews Genetics 5:435-445. doi: 10.1038/nrg1348.
15. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917-921. doi: 10.1038/nature03445.
16. Fischer F, Baerenfaller K, Jiricny J. 2007. 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems. Gastroenterology 133:1858-1868. doi: 10.1053/j.gastro.2007.09.003.
17. Ham MF, Takakuwa T, Luo WJ, Liu A, Horii A, Aozasa K. 2006. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability. Cancer Science 97:226-234. doi: 10.1111/j.1349-7006.2006.00165.x.
18. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. 2008. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Journal of Clinical Oncology 26:5783-5788. doi: 10.1200/JCO.2008.17.5950.
19. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. 2005. Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer). The New England Journal of Medicine 352:1851-1860. doi: 10.1056/NEJMoa043146.
20. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A. 2006. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Research 66:7810-7817. doi: 10.1158/0008-5472.CAN-06-1114.
21. Haw RA, Croft D, Yung CK, Ndegwa N, D'Eustachio P, Hermjakob H, Stein LD. 2011. The reactome BioMart. Database 2011:bar031. doi: 10.1093/database/bar031.
22. Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A. 2010. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nature Reviews Clinical Oncology 7:197-208. doi: 10.1038/nrclinonc.2010.18.
23. Hodgkinson A, Eyre-Walker A. 2011. Variation in the mutation rate across mammalian genomes. Nature Reviews Genetics 12:756-766. doi: 10.1038/nrg3098.
24. Hombauer H, Campbell CS, Smith CE, Desai A, Kolodner RD. 2011. Visualization of eukaryotic DNA mismatch repair reveals distinct recognition and repair intermediates. Cell 147:1040-1053. doi: 10.1016/j.cell.2011.10.025.
25. Jiricny J. 2006. The multifaceted mismatch-repair system. Nature Reviews Molecular Cell Biology 7:335-346. doi: 10.1038/nrm1907.
26. Kandoth C, Cancer Genome Atlas Research Network, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. 2013. Integrated genomic characterization of endometrial carcinoma. Nature 497:67-73. doi: 10.1038/nature12113.
27. Kim TM, Laird PW, Park PJ. 2013. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 155:858-868. doi: 10.1016/j.cell.2013.10.015.
28. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, Steinberg S, Helgason H, Thorleifsson G, Gudbjartsson DF, Helgason A, Magnusson OT, Thorsteinsdottir U, Stefansson K. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488:471-475. doi: 10.1038/nature11396.
29. Koren A, Polak P, Nemesh J, Michaelson JJ, Sebat J, Sunyaev SR, McCarroll SA. 2012. Differential relationship of DNA replication timing to different forms of human mutation and variation. American Journal of Human Genetics 91:1033-1040. doi: 10.1016/j.ajhg.2012.10.018.
30. Kunkel TA, Soni A. 1988. Mutagenesis by transient misalignment. The Journal of Biological Chemistry 263:14784-14789.
31. Li H, Durbin R. 2010. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595. doi: 10.1093/bioinformatics/btp698.
32. Martin SA, McCabe N, Mullarkey M, Cummins R, Burgess DJ, Nakabeppu Y, Oka S, Kay E, Lord CJ, Ashworth A. 2010. DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell 17:235-248. doi: 10.1016/j.ccr.2009.12.046.
33. Martin SA, Hewish M, Sims D, Lord CJ, Ashworth A. 2011. Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers. Cancer Research 71:1836-1848. doi: 10.1158/0008-5472.CAN-10-2836.
34. McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'Connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A. 2006. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Research 66:8109-8115. doi: 10.1158/0008-5472.CAN-06-0140.
35. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research 20:1297-1303. doi: 10.1101/gr.107524.110.
36. Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jnr, Ellis P, Di Leo A, Baselga J, Sotiriou C, Piccart-Gebhart M. 2012. Dissecting the heterogeneity of triple-negative breast cancer. Journal of Clinical Oncology 30:1879-1887. doi: 10.1200/JCO.2011.38.2010.
37. Miquel C, Jacob S, Grandjouan S, Aimé A, Viguier J, Sabourin JC, Sarasin A, Duval A, Praz F. 2007. Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability. Oncogene 26:5919-5926. doi: 10.1038/sj.onc.1210419.
38. Montgomery SB, Goode DL, Kvikstad E, Albers CA, Zhang ZD, Mu XJ, Ananda G, Howie B, Karczewski KJ, Smith KS, Anaya V, Richardson R, Davis J, 1000 Genomes Project Consortium, MacArthur DG, Sidow A, Duret L, Gerstein M, Makova KD, Marchini J, McVean G, Lunter G. 2013. The origin, evolution, and functional impact of short insertion-deletion variants identified in 179 human genomes. Genome Research 23:749-761. doi: 10.1101/gr.148718.112.
39. Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y. 2012. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Research 72:5588-5599. doi: 10.1158/0008-5472.CAN-12-2753.
40. Ng K, Schrag D. 2010. Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? Journal of Clinical Oncology 28:3207-3210. doi: 10.1200/JCO.2010.28.9314.
41. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Borg Å, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979-993. doi: 10.1016/j.cell.2012.04.024.
42. Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, Sherborne A, Chubb D, Carvajal-Carmona LG, Ma Y, Kaur K, Dobbins S, Barclay E, Gorman M, Martin L, Kovac MB, Humphray S, CORGI Consortium, WGS500 Consortium, Lucassen A, Holmes CC, Bentley D, Donnelly P, Taylor J, Petridis C, Roylance R, Sawyer EJ, Kerr DJ, Clark S, Grimes J, Kearsey SE, Thomas HJ, McVean G, Houlston RS, Tomlinson I. 2013. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nature Genetics 45:136-144. doi: 10.1038/ng.2503.
43. Park JM, Huang S, Tougeron D, Sinicrope FA. 2013. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. PLOS ONE 8:e65369. doi: 10.1371/journal.pone.0065369.
44. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. 2012. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. Journal of Medical Genetics 49:151-157. doi: 10.1136/jmedgenet-2011-100714.
45. Peltomaki P. 2014. Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Clinical Genetics 85:403-412. doi: 10.1111/cge.12349.
46. Pena-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Borán M, Castor D, Lopes M, Sartori AA, Jiricny J. 2012. Noncanonical mismatch repair as a source of genomic instability in human cells. Molecular Cell 47:669-680. doi: 10.1016/j.molcel.2012.07.006.
47. Pinol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. 2005. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. The Journal of the American Medical Association 293:1986-1994.
48. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordóñez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR. 2010. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463:191-196. doi: 10.1038/nature08658.
49. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordoñez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ. 2010. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184-190. doi: 10.1038/nature08629.
50. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842. doi: 10.1093/bioinformatics/btq033.
51. Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J. 2011. Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nature Biotechnology 30:61-68. doi: 10.1038/nbt.2053.
52. Richman SD, Seymour MT, Chambers P, Elliott F, Daly CL, Meade AM, Taylor G, Barrett JH, Quirke P. 2009. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. Journal of Clinical Oncology 27:5931-5937. doi: 10.1200/JCO.2009.22.4295.
53. Saint-Ruf C, Matic I. 2006. Environmental tuning of mutation rates. Environmental Microbiology 8:193-199. doi: 10.1111/j.1462-2920.2005.00968.x.
54. Shell SS, Putnam CD, Kolodner RD. 2007. The N terminus of Saccharomyces cerevisiae Msh6 is an unstructured tether to PCNA. Molecular Cell 26:565-578. doi: 10.1016/j.molcel.2007.04.024.
55. Smith CG, Fisher D, Claes B, Maughan TS, Idziaszczyk S, Peuteman G, Harris R, James MD, Meade A, Jasani B, Adams RA, Kenny S, Kaplan R, Lambrechts D, Cheadle JP. 2013. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy {+/-} cetuximab. Clinical Cancer Research 19:4104-4113. doi: 10.1158/1078-0432.CCR-12-2581.
56. Song CX, Clark TA, Lu XY, Kislyuk A, Dai Q, Turner SW, He C, Korlach J. 2012. Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine. Nature Methods 9:75-77. doi: 10.1038/nmeth.1779.
57. Stamatoyannopoulos JA, Adzhubei I, Thurman RE, Kryukov GV, Mirkin SM, Sunyaev SR. 2009. Human mutation rate associated with DNA replication timing. Nature Genetics 41:393-395. doi: 10.1038/ng.363.
58. Takahashi M, Koi M, Balaguer F, Boland CR, Goel A. 2011. MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor. The Journal of Biological Chemistry 286:12157-12165. doi: 10.1074/jbc.M110.198804.
59. Tan YY, McGaughran J, Ferguson K, Walsh MD, Buchanan DD, Young JP, Webb PM, Obermair A, Spurdle AB, ANECS Group. 2013. Improving identification of lynch syndrome patients: a comparison of research data with clinical records. International Journal of Cancer 132:2876-2883. doi: 10.1002/ijc.27978.
60. TCGA. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337. doi: 10.1038/nature11252.
61. Tie J, Lipton L, Desai J, Gibbs P, Jorissen RN, Christie M, Drummond KJ, Thomson BN, Usatoff V, Evans PM, Pick AW, Knight S, Carne PW, Berry R, Polglase A, McMurrick P, Zhao Q, Busam D, Strausberg RL, Domingo E, Tomlinson IP, Midgley R, Kerr D, Sieber OM. 2011. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clinical Cancer Research 17:1122-1130. doi: 10.1158/1078-0432.CCR-10-1720.
62. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN. 2010. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of USA 107:16910-16915. doi: 10.1073/pnas.1009843107.
63. Vichai V, Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols 1:1112-1116. doi: 10.1038/nprot.2006.179.
64. Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, Mukherjee B, Iniesta MD, Morgan MA, Rennert G, Gruber SB. 2011. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer Research 71:2632-2642. doi: 10.1158/0008-5472.CAN-10-1120.
65. Watson JV, Chambers SH, Smith PJ. 1987. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 8:1-8. doi: 10.1002/cyto.990080101.
66. Wheeler DA, Wang L. 2013. From human genome to cancer genome: the first decade. Genome Research 23:1054-1062. doi: 10.1101/gr.157602.113.
67. Yoon K, Lee S, Han TS, Moon SY, Yun SM, Kong SH, Jho S, Choe J, Yu J, Lee HJ, Park JH, Kim HM, Lee SY, Park J, Kim WH, Bhak J, Yang HK, Kim SJ. 2013. Comprehensive genome-and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Research 23:1109-1117. doi: 10.1101/gr.145706.112.
68. Zook JM, Chapman B, Wang J, Mittelman D, Hofmann O, Hide W, Salit M. 2014. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nature Biotechnology 32:246-251. doi: 10.1038/nbt.2835.